mk-0616
merck
['cardio']
#acc23/#wccardio #jacc lbct simpub: mk-0616 demonstrated statistically sig. &amp; robust dose-dependent placebo-adjusted reductions in #ldl-c at week 8 of up to 60.9% from baseline, &amp; was well tolerated over 8 weeks of tx &amp; an add'l 8 weeks of follow up #pcsk9 
Official account representing the ACC's #JACCJournals, one of the most widely read & most impactful CV journal programs in the world. @ACCinTouch #JACC